{"id": "1377636950753083393", "creation": 1617289218.0, "user_id": "132897310", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "A new Phase I trial will evaluate the safety and immunogenicity of Moderna's new, variant specific mRNA-1273.351 vaccine candidate in 200 healthy adult volunteers.\n#Covid19 #vaccine #biopharma #clinicaltrials\nRead the news: https://t.co/31Xb0rKctc https://t.co/6bQ5YekMMb", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#BIOPHARMA", "#CLINICALTRIALS"]}